相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Measurement of spleen size using gamma camera scintigraphy in essential thrombocythaemia
Peter Revesz et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Assessment of spleen size using gamma camera scintigraphy in newly diagnosed patients with essential thrombocythaemia and polycythaemia vera
Jan Carneskog et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: a population-based study of 311 patients
F. Girodon et al.
LEUKEMIA (2010)
Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms
Domenica Caramazza et al.
ANNALS OF HEMATOLOGY (2009)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Leukocytosis at Diagnosis and the Risk of Subsequent Thrombosis in Patients With Low-Risk Essential Thrombocythemia and Polycythemia Vera
Naseema Gangat et al.
CANCER (2009)
AML transformation in 56 patients with Ph- MPD in two well defined populations
Khadija Abdulkarim et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis
Francesco Passamonti et al.
BLOOD (2008)
20+yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis
Ayalew Tefferi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients
Francesco Passamonti et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Risk factors of long-term incidences of thrombosis, myelofibrosis and evolution into malignance in polycythemia vera: a single center experience from China
Jie Bai et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders
F. Cervantes et al.
LEUKEMIA (2008)
Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
A. Tefferi et al.
LEUKEMIA (2008)
Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes
Bridget S. Wilkins et al.
BLOOD (2008)
Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden
A. M. Vannucchi et al.
LEUKEMIA (2007)
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelotibrosis: recommendations from an ad hoc international expert panel
Ayalew Tefferi et al.
BLOOD (2007)
Essential thrombocythemia in young individuals:: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients
A. Alvarez-Larran et al.
LEUKEMIA (2007)
Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera
A. Tefferi et al.
LEUKEMIA (2007)
Classification of Ph-negative chronic myeloproliferative disorders - Morphology as the yardstick of classification
Hans Michael Kvasnicka et al.
PATHOBIOLOGY (2007)
Essential thrombocythemia beyond the first decade: Life expectancy, long-term complication rates, and prognostic factors
AP Wolanskyj et al.
MAYO CLINIC PROCEEDINGS (2006)
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status:: a prospective study
PJ Campbell et al.
LANCET (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Goteborg, Sweden, during 1983-99
P Johansson et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia
F Passamonti et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Incidence of chronic myeloproliferative disorders in the city of Goteborg, Sweden 1983-1992
B Ridell et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2000)
分享论文
